Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Medigen Biotechnology (3176)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
39.50 +0.50    +1.28%
14/05 - Closed. Currency in TWD ( Disclaimer )
  • Volume: 169
  • Bid/Ask: 74.60 / 74.70
  • Day's Range: 38.65 - 39.50
Type:  Equity
Market:  Taiwan
ISIN:  TW0003176004 
Medigen BioTech 39.50 +0.50 +1.28%

3176 Balance Sheet

 
Assess the latest Medigen Biotechnology balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 3176 Annual Report data, financial summaries and charts are available for Medigen Biotechnology investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 5708.04 6069.59 6137.07 6255.28
Cash and Short Term Investments 4587.51 4458.29 4647.08 4903.86
Cash - - - -
Cash & Equivalents 2222.93 1262.41 1473.49 1714.09
Short Term Investments 2364.1 3195.4 3172.8 3189
Total Receivables, Net 453.61 532.05 306.03 224.17
Accounts Receivables - Trade, Net 328.89 403.93 206.92 151.67
Total Inventory 546.91 999.44 1039.08 699.5
Prepaid Expenses 33.61 33.2 90.32 382.46
Other Current Assets, Total 86.4 46.61 54.56 45.29
Total Assets 8527.24 9120.88 9259.86 9481.19
Property/Plant/Equipment, Total - Net 2043.21 2121.88 2153.73 2175.79
Property/Plant/Equipment, Total - Gross 3359.75 3424.07 3419.57 3408.63
Accumulated Depreciation, Total -1316.54 -1302.19 -1265.84 -1232.84
Goodwill, Net 76.18 76.18 76.18 76.18
Intangibles, Net 106.54 107.96 108.79 110.09
Long Term Investments 292.87 296.17 339.87 338.08
Note Receivable - Long Term 124.72 128.12 99.11 72.5
Other Long Term Assets, Total 49.1 45.78 39.2 121.29
Other Assets, Total 2795.6 4113.21 4366.23 4114.88
Total Current Liabilities 2779.89 2640.81 2681.07 884.27
Accounts Payable 122.57 100.94 127.08 114.24
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 402.6 333 393 328
Current Port. of LT Debt/Capital Leases 1745.73 1730.27 1716.91 46.01
Other Current liabilities, Total 508.99 476.6 444.08 396.03
Total Liabilities 3530.12 3405.52 3458.44 3343.19
Total Long Term Debt 716.63 730.91 743.1 2401.6
Long Term Debt 449.1 459.12 467.05 2130.62
Capital Lease Obligations 267.53 271.79 276.05 270.98
Deferred Income Tax 14.15 14.17 14.2 14.22
Minority Interest 3405.49 3851.35 3900.19 4167.17
Other Liabilities, Total -3788.64 -4968.86 -5139.26 -5258.24
Total Equity 4997.13 5715.36 5801.42 6138
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1393.46 1393.46 1393.46 1394.46
Additional Paid-In Capital 968.14 930.61 917.91 1429.8
Retained Earnings (Accumulated Deficit) -747.51 -425.4 -378.29 -822.67
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 3383.03 3816.69 3868.34 4136.42
Total Liabilities & Shareholders' Equity 8527.24 9120.88 9259.86 9481.19
Total Common Shares Outstanding 139.35 139.35 139.45 139.45
Total Preferred Shares Outstanding - - - -
* In Millions of TWD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

3176 Price Commentary

Write your thoughts about Medigen Biotechnology
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email